Anifrolumab
ATC L04AG11 · 9 markets · 16 records
AU 4 records · 4 strengths
- 300 mg/2 mLinjectionSAPHNELO
- 300 mginjectionSAPHNELO anifrolumab 300 mg concentrated injection vial
- 120 mginjectionSAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 2 strengths
CA 2 records · 2 strengths
ES 2 records · 2 strengths
- 300 mginjectionSAPHNELO
- 120 mginjectionSAPHNELO PRECARGADA
MX 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
- 150 mginjectionSAPHNELO 150 mg/ml Concentrate for Solution for Infusion莎芙諾注射劑 150毫克/毫升
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 300 mg/2 mLinjectionSAPHNELO 300 mg, solution à diluer pour perfusion
| Strength / form / release | US | CA | AU | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|
| 300 mg/2 mL injection | SAPHNELO | SAPHNELO | SAPHNELO 300 mg, solution à diluer pour perfusion | ||||||
| 300 mg injection | SAPHNELO anifrolumab 300 mg concentrated injection vial | SAPHNELO | |||||||
| 150 mg injection | SAPHNELO 150 mg/ml Concentrate for Solution for Infusion 莎芙諾注射劑 150毫克/毫升 | ||||||||
| 120 mg injection | SAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen | SAPHNELO PRECARGADA | |||||||
| 150 mg liquid | SAPHNELO | ||||||||
| 120 mg liquid | SAPHNELO | ||||||||
| 120 mg/0.8 mL injection | SAPHNELO | ||||||||
unknown | SAPHNELO | SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/2ML | SAPHNELO | ||||||
liquid | SAPHNELO SAPHNELO SC |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in MX · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · TW 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 MX · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.